THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST
It’s hard to think of something as being rare when it affects up to 30 million Americans and 300 million people worldwide. But the truth is there are more than 6,000 conditions – those affecting 200,000 people or fewer – that are considered rare.
Today, February 28th, is Rare Disease Day. It’s a day to remind ourselves of the millions of people, and their families, struggling with these diseases. These conditions are also called or orphan diseases because, in many cases, drug companies were not interested in adopting them to develop treatments.
At the California Institute for Regenerative Medicine (CIRM), we have no such reservations. In fact last Friday our governing Board voted to invest almost $12 million to support a clinical trial for IPEX syndrome. IPEX syndrome is a condition where the body can’t control or restrain an immune response, so the person’s immune cells attack their own healthy tissue. This leads to the development of Type 1 diabetes, severe eczema, damage to the small intestines and kidneys and failure to thrive. It’s diagnosed in infancy, most of those affected are boys, and it is often fatal.
IPEX is one of two dozen rare diseases that CIRM is funding a clinical trial for. In fact, more than one third of all the projects we fund target a rare disease or condition. Those include:
- Retinitis pigmentosa
- Sickle cell disease
- Huntington’s disease
- Severe combined immunodeficiency (SCID)
- Amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease)
- Alpha thalassemia major
- Duchenne Muscular Dystrophy
- Leukocyte adhesion deficiency
- X-linked CGD
- Spina bifida
Some might question the wisdom of investing hundreds of millions of dollars in conditions that affect a relatively small number of patients. But if you see the faces of these patients and get to know their families, as we do, you know that often agencies like CIRM are their only hope.
Dr. Maria Millan, CIRM’s President and CEO, says the benefits of one successful approach can often extend far beyond one rare disease.
“Children with IPEX syndrome clearly represent a group of patients with an unmet medical need, and this therapy could make a huge difference in their lives. Success of this treatment in this rare disease presents far-reaching potential to develop treatments for a larger number of patients with a broad array of immune disorders.”
CIRM is proud to fund and spread awareness of rare diseases and invites you to watch this video about how they affect families around the world.
4 thoughts on “Joining the movement to fight rare diseases”
Pingback: Rare Disease: An Uphill Battle for Diagnosis and Treatment | The Stem Cellar
Do you have stem cell treatment for Schitzophrenia
I am afraid not Leonore. I don’t know of any stem cell or gene therapy for schizophrenia yet.
Pingback: Join the movement to fight rare diseases | The Stem Cellar